Atlas Trials

Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT02614508 · TERMINATED

Trial details

NCT number
NCT02614508
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Small Lymphocytic Lymphoma
Start date
2016-01-01
Primary completion
2019-08-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.